Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Sep;92(3):1302–1313. doi: 10.1172/JCI116704

Analysis of human antitopoisomerase-I idiotypes.

D Vazquez-Abad 1, V Pascual 1, M Zanetti 1, N F Rothfield 1
PMCID: PMC288272  PMID: 8397223

Abstract

Antibodies to topoisomerase-I are present in approximately 26% of patients with scleroderma and are rarely found in patients with other diseases. In the current study, the expression of the antitopoisomerase-I (antitopo-I) idiotype from two scleroderma patients (E.M. and S.G.) and from a healthy individual (N.M.) were studied. Idiotype EM-SCL was restricted to the three classes of antitopo-I, whereas idiotypes SG-SCL and NM were found in all classes of antitopo-I as well as in their non-antitopo-I Igs. Sera from 9 of 10 antitopo-I-positive unrelated scleroderma patients expressed idiotype SG-SCL and some also expressed idiotype NM. Sera from N.M.'s 3 daughters and from 7 of 18 nonrelated normals expressed idiotype NM in the three immunoglobulin classes of non-antitopo-I. Two of the antitopo-I antibodies expressed a cross-reacting idiotype (CRI) that is present in non-antitopo-I antibodies from the same donor. Contrary to the natural CRI, SG-SCL's CRI is closely associated with the antigen binding site. Antitopo-I idiotypes are on the heavy chains. Like many other autoantibodies, Id-SG-SCL use VH4.2-1, DXP1, and JH4 in germline configuration.

Full text

PDF
1302

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behar S. M., Scharff M. D. Somatic diversification of the S107 (T15) VH11 germ-line gene that encodes the heavy-chain variable region of antibodies to double-stranded DNA in (NZB x NZW)F1 mice. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3970–3974. doi: 10.1073/pnas.85.11.3970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berek C. Molecular dissection of an antigen-specific immune response. J Autoimmun. 1989 Jun;2 (Suppl):195–201. doi: 10.1016/0896-8411(89)90131-5. [DOI] [PubMed] [Google Scholar]
  3. Cairns E., Kwong P. C., Misener V., Ip P., Bell D. A., Siminovitch K. A. Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. Implications for the molecular basis of human autoimmune responses. J Immunol. 1989 Jul 15;143(2):685–691. [PubMed] [Google Scholar]
  4. Capra J. D. Immunoglobulin VH genes in systemic lupus erythematosus. Curr Opin Rheumatol. 1989 Oct;1(3):343–346. doi: 10.1097/00002281-198901030-00017. [DOI] [PubMed] [Google Scholar]
  5. Chen C., Stenzel-Poore M. P., Rittenberg M. B. Natural auto- and polyreactive antibodies differing from antigen-induced antibodies in the H chain CDR3. J Immunol. 1991 Oct 1;147(7):2359–2367. [PubMed] [Google Scholar]
  6. Chen P. P., Liu M. F., Glass C. A., Sinha S., Kipps T. J., Carson D. A. Characterization of two immunoglobulin VH genes that are homologous to human rheumatoid factors. Arthritis Rheum. 1989 Jan;32(1):72–76. doi: 10.1002/anr.1780320112. [DOI] [PubMed] [Google Scholar]
  7. Chen P. P., Liu M. F., Sinha S., Carson D. A. A 16/6 idiotype-positive anti-DNA antibody is encoded by a conserved VH gene with no somatic mutation. Arthritis Rheum. 1988 Nov;31(11):1429–1431. doi: 10.1002/art.1780311113. [DOI] [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Crowley J. J., Goldfien R. D., Schrohenloher R. E., Spiegelberg H. L., Silverman G. J., Mageed R. A., Jefferis R., Koopman W. J., Carson D. A., Fong S. Incidence of three cross-reactive idiotypes on human rheumatoid factor paraproteins. J Immunol. 1988 May 15;140(10):3411–3418. [PubMed] [Google Scholar]
  10. D'Arpa P., Machlin P. S., Ratrie H., 3rd, Rothfield N. F., Cleveland D. W., Earnshaw W. C. cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2543–2547. doi: 10.1073/pnas.85.8.2543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. D'Arpa P., White-Cooper H., Cleveland D. W., Rothfield N. F., Earnshaw W. C. Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients. Arthritis Rheum. 1990 Oct;33(10):1501–1511. doi: 10.1002/art.1780331007. [DOI] [PubMed] [Google Scholar]
  12. Davidson A., Preud'homme J. L., Solomon A., Chang M. D., Beede S., Diamond B. Idiotypic analysis of myeloma proteins: anti-DNA activity of monoclonal immunoglobulins bearing an SLE idiotype is more common in IgG than IgM antibodies. J Immunol. 1987 Mar 1;138(5):1515–1518. [PubMed] [Google Scholar]
  13. Davidson A., Smith A., Katz J., Preud'Homme J. L., Solomon A., Diamond B. A cross-reactive idiotype on anti-DNA antibodies defines a H chain determinant present almost exclusively on IgG antibodies. J Immunol. 1989 Jul 1;143(1):174–180. [PubMed] [Google Scholar]
  14. Dersimonian H., Schwartz R. S., Barrett K. J., Stollar B. D. Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies. J Immunol. 1987 Oct 1;139(7):2496–2501. [PubMed] [Google Scholar]
  15. Douvas A. S., Achten M., Tan E. M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem. 1979 Oct 25;254(20):10514–10522. [PubMed] [Google Scholar]
  16. French D. L., Laskov R., Scharff M. D. The role of somatic hypermutation in the generation of antibody diversity. Science. 1989 Jun 9;244(4909):1152–1157. doi: 10.1126/science.2658060. [DOI] [PubMed] [Google Scholar]
  17. Gilbert D., Margaritte C., Payelle-Brogart B., Tron F. Development of the B cell anti-DNA repertoire in (NZB x NZW)F1 mice. Relationship with the natural autoimmune repertoire. J Immunol. 1992 Sep 1;149(5):1795–1801. [PubMed] [Google Scholar]
  18. Gorevic P. D., Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol. 1991 Apr;28(2):79–94. [PubMed] [Google Scholar]
  19. Heck M. M., Hittelman W. N., Earnshaw W. C. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1086–1090. doi: 10.1073/pnas.85.4.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hildebrandt S., Noell G. S., Vazquez-Abad D., Earnshaw W. C., Zanetti M., Rothfield N. F. Idiotypic analysis of human anti-topoisomerase I autoantibodies. Autoimmunity. 1991;10(1):41–48. doi: 10.3109/08916939108997146. [DOI] [PubMed] [Google Scholar]
  21. Hildebrandt S., Weiner E. S., Senecal J. L., Noell G. S., Earnshaw W. C., Rothfield N. F. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay. Clin Immunol Immunopathol. 1990 Dec;57(3):399–410. doi: 10.1016/0090-1229(90)90114-6. [DOI] [PubMed] [Google Scholar]
  22. Hildebrandt S., Weiner E., Senécal J. L., Noell S., Daniels L., Earnshaw W. C., Rothfield N. F. The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies. Arthritis Rheum. 1990 May;33(5):724–727. doi: 10.1002/art.1780330515. [DOI] [PubMed] [Google Scholar]
  23. Hoffmann A., Heck M. M., Bordwell B. J., Rothfield N. F., Earnshaw W. C. Human autoantibody to topoisomerase II. Exp Cell Res. 1989 Feb;180(2):409–418. doi: 10.1016/0014-4827(89)90067-0. [DOI] [PubMed] [Google Scholar]
  24. Honjo T. Immunoglobulin genes. Annu Rev Immunol. 1983;1:499–528. doi: 10.1146/annurev.iy.01.040183.002435. [DOI] [PubMed] [Google Scholar]
  25. Iwai K., Tsubata T., Katsura Y., Kumagai S., Imura H. Qualitative difference of anti-DNA antibody-producing cell precursors in the pre-immune B cell repertoire between normal and lupus-prone mice. Clin Exp Immunol. 1991 Oct;86(1):106–111. doi: 10.1111/j.1365-2249.1991.tb05781.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jefferies L. C., Silverman G. J., Carchidi C. M., Silberstein L. E. Idiotypic heterogeneity of VKIII autoantibodies to red blood cell antigens. Clin Immunol Immunopathol. 1992 Nov;65(2):119–128. doi: 10.1016/0090-1229(92)90214-9. [DOI] [PubMed] [Google Scholar]
  27. Juarez C., Vila J. L., Gelpi C., Agusti M., Amengual M. J., Martinez M. A., Rodriguez J. L. Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunosorbent assay. Arthritis Rheum. 1988 Jan;31(1):108–115. doi: 10.1002/art.1780310115. [DOI] [PubMed] [Google Scholar]
  28. Kang C. Y., Brunck T. K., Kieber-Emmons T., Blalock J. E., Kohler H. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. Science. 1988 May 20;240(4855):1034–1036. doi: 10.1126/science.3368787. [DOI] [PubMed] [Google Scholar]
  29. Kipps T. J., Tomhave E., Chen P. P., Fox R. I. Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjogren's syndrome. J Immunol. 1989 Jun 15;142(12):4261–4268. [PubMed] [Google Scholar]
  30. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  31. Mageed R. A., Dearlove M., Goodall D. M., Jefferis R. Immunogenic and antigenic epitopes of immunoglobulins. XVII--Monoclonal antibodies reactive with common and restricted idiotopes to the heavy chain of human rheumatoid factors. Rheumatol Int. 1986;6(4):179–183. doi: 10.1007/BF00541285. [DOI] [PubMed] [Google Scholar]
  32. Mageed R. A., MacKenzie L. E., Stevenson F. K., Yuksel B., Shokri F., Maziak B. R., Jefferis R., Lydyard P. M. Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood. J Exp Med. 1991 Jul 1;174(1):109–113. doi: 10.1084/jem.174.1.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mageed R. A., Walker M. R., Jefferis R. Restricted light chain subgroup expression on human rheumatoid factor paraproteins determined by monoclonal antibodies. Immunology. 1986 Nov;59(3):473–478. [PMC free article] [PubMed] [Google Scholar]
  34. Maricq H. R., Weinrich M. C., Keil J. E., Smith E. A., Harper F. E., Nussbaum A. I., LeRoy E. C., McGregor A. R., Diat F., Rosal E. J. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum. 1989 Aug;32(8):998–1006. doi: 10.1002/anr.1780320809. [DOI] [PubMed] [Google Scholar]
  35. Marion T. N., Bothwell A. L., Briles D. E., Janeway C. A., Jr IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection. J Immunol. 1989 Jun 15;142(12):4269–4274. [PubMed] [Google Scholar]
  36. Marks J. D., Tristem M., Karpas A., Winter G. Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur J Immunol. 1991 Apr;21(4):985–991. doi: 10.1002/eji.1830210419. [DOI] [PubMed] [Google Scholar]
  37. Martin T., Duffy S. F., Carson D. A., Kipps T. J. Evidence for somatic selection of natural autoantibodies. J Exp Med. 1992 Apr 1;175(4):983–991. doi: 10.1084/jem.175.4.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Meek K., Takei M., Dang H., Sanz I., Dauphinée M. J., Capra J. D., Talal N. Anti-peptide antibodies detect a lupus-related interspecies idiotype that maps to H chain CDR2. J Immunol. 1990 Feb 15;144(4):1375–1381. [PubMed] [Google Scholar]
  39. Milstein C. From the structure of antibodies to the diversification of the immune response. EMBO J. 1985 May;4(5):1083–1092. doi: 10.1002/j.1460-2075.1985.tb03744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Muryoi T., Kasturi K. N., Kafina M. J., Cram D. S., Harrison L. C., Sasaki T., Bona C. A. Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes. J Exp Med. 1992 Apr 1;175(4):1103–1109. doi: 10.1084/jem.175.4.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Muryoi T., Kasturi K. N., Kafina M. J., Saitoh Y., Usuba O., Perlish J. S., Fleischmajer R., Bona C. A. Self reactive repertoire of tight skin mouse: immunochemical and molecular characterization of anti-topoisomerase I autoantibodies. Autoimmunity. 1991;9(2):109–117. doi: 10.3109/08916939109006746. [DOI] [PubMed] [Google Scholar]
  42. Oddou P., Schmidt U., Knippers R., Richter A. Monoclonal antibodies neutralizing mammalian DNA topoisomerase I activity. Eur J Biochem. 1988 Nov 15;177(3):523–529. doi: 10.1111/j.1432-1033.1988.tb14404.x. [DOI] [PubMed] [Google Scholar]
  43. Olee T., Yang P. M., Siminovitch K. A., Olsen N. J., Hillson J., Wu J., Kozin F., Carson D. A., Chen P. P. Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases. J Clin Invest. 1991 Jul;88(1):193–203. doi: 10.1172/JCI115277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pascual V., Capra J. D. B-cell superantigens? Curr Biol. 1991 Oct;1(5):315–317. doi: 10.1016/0960-9822(91)90097-g. [DOI] [PubMed] [Google Scholar]
  45. Pascual V., Capra J. D. VH4-21, a human VH gene segment overrepresented in the autoimmune repertoire. Arthritis Rheum. 1992 Jan;35(1):11–18. doi: 10.1002/art.1780350103. [DOI] [PubMed] [Google Scholar]
  46. Pascual V., Victor K., Lelsz D., Spellerberg M. B., Hamblin T. J., Thompson K. M., Randen I., Natvig J., Capra J. D., Stevenson F. K. Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol. 1991 Jun 15;146(12):4385–4391. [PubMed] [Google Scholar]
  47. Pascual V., Victor K., Randen I., Thompson K., Natvig J. B., Capra J. D. IgM rheumatoid factors in patients with rheumatoid arthritis derive from a diverse array of germline immunoglobulin genes and display little evidence of somatic variation. J Rheumatol Suppl. 1992 Jan;32:50–53. [PubMed] [Google Scholar]
  48. Pascual V., Victor K., Spellerberg M., Hamblin T. J., Stevenson F. K., Capra J. D. VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol. 1992 Oct 1;149(7):2337–2344. [PubMed] [Google Scholar]
  49. Reidl L. S., Friedman D. F., Goldman J., Hardy R. R., Jefferies L. C., Silberstein L. E. Structural basis of a conserved idiotope expressed by an autoreactive human B cell lymphoma. Evidence that a VH CDR3 mutation alters idiotypy and specificity. J Immunol. 1991 Nov 15;147(10):3623–3631. [PubMed] [Google Scholar]
  50. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  51. Sanger F., Coulson A. R., Barrell B. G., Smith A. J., Roe B. A. Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol. 1980 Oct 25;143(2):161–178. doi: 10.1016/0022-2836(80)90196-5. [DOI] [PubMed] [Google Scholar]
  52. Sanz I., Dang H., Takei M., Talal N., Capra J. D. VH sequence of a human anti-Sm autoantibody. Evidence that autoantibodies can be unmutated copies of germline genes. J Immunol. 1989 Feb 1;142(3):883–887. [PubMed] [Google Scholar]
  53. Sasso E. H., Silverman G. J., Mannik M. Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup. J Immunol. 1991 Sep 15;147(6):1877–1883. [PubMed] [Google Scholar]
  54. Shero J. H., Bordwell B., Rothfield N. F., Earnshaw W. C. Antibodies to topoisomerase I in sera from patients with scleroderma. J Rheumatol Suppl. 1987 Jun;14 (Suppl 13):138–140. [PubMed] [Google Scholar]
  55. Shero J. H., Bordwell B., Rothfield N. F., Earnshaw W. C. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science. 1986 Feb 14;231(4739):737–740. doi: 10.1126/science.3003910. [DOI] [PubMed] [Google Scholar]
  56. Shlomchik M. J., Marshak-Rothstein A., Wolfowicz C. B., Rothstein T. L., Weigert M. G. The role of clonal selection and somatic mutation in autoimmunity. 1987 Aug 27-Sep 2Nature. 328(6133):805–811. doi: 10.1038/328805a0. [DOI] [PubMed] [Google Scholar]
  57. Shlomchik M., Mascelli M., Shan H., Radic M. Z., Pisetsky D., Marshak-Rothstein A., Weigert M. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med. 1990 Jan 1;171(1):265–292. doi: 10.1084/jem.171.1.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Shuster A. M., Gololobov G. V., Kvashuk O. A., Bogomolova A. E., Smirnov I. V., Gabibov A. G. DNA hydrolyzing autoantibodies. Science. 1992 May 1;256(5057):665–667. doi: 10.1126/science.1585181. [DOI] [PubMed] [Google Scholar]
  59. Silverman G. J., Goldfien R. D., Chen P., Mageed R. A., Jefferis R., Goñi F., Frangione B., Fong S., Carson D. A. Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest. 1988 Aug;82(2):469–475. doi: 10.1172/JCI113620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Silverman G. J., Goñi F., Fernandez J., Chen P. P., Frangione B., Carson D. A. Distinct patterns of heavy chain variable region subgroup use by human monoclonal autoantibodies of different specificity. J Exp Med. 1988 Dec 1;168(6):2361–2366. doi: 10.1084/jem.168.6.2361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Siminovitch K. A., Misener V., Kwong P. C., Song Q. L., Chen P. P. A natural autoantibody is encoded by germline heavy and lambda light chain variable region genes without somatic mutation. J Clin Invest. 1989 Nov;84(5):1675–1678. doi: 10.1172/JCI114347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Sollazzo M., Castiglia D., Billetta R., Tramontano A., Zanetti M. Structural definition by antibody engineering of an idiotypic determinant. Protein Eng. 1990 May;3(6):531–539. doi: 10.1093/protein/3.6.531. [DOI] [PubMed] [Google Scholar]
  63. Spitzer R. E., Stitzel A. E., Tsokos G. C. Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinity. J Immunol. 1992 Jan 1;148(1):137–141. [PubMed] [Google Scholar]
  64. Steinitz M., Klein G., Koskimies S., Makel O. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature. 1977 Sep 29;269(5627):420–422. doi: 10.1038/269420a0. [DOI] [PubMed] [Google Scholar]
  65. Stevenson F. K., Wrightham M., Glennie M. J., Jones D. B., Cattan A. R., Feizi T., Hamblin T. J., Stevenson G. T. Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood. 1986 Aug;68(2):430–436. [PubMed] [Google Scholar]
  66. Tabor S., Richardson C. C. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proc Natl Acad Sci U S A. 1987 Jul;84(14):4767–4771. doi: 10.1073/pnas.84.14.4767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Thompson K. M., Sutherland J., Barden G., Melamed M. D., Randen I., Natvig J. B., Pascual V., Capra J. D., Stevenson F. K. Human monoclonal antibodies against blood group antigens preferentially express a VH4-21 variable region gene-associated epitope. Scand J Immunol. 1991 Oct;34(4):509–518. doi: 10.1111/j.1365-3083.1991.tb01574.x. [DOI] [PubMed] [Google Scholar]
  68. Weiner E. S., Earnshaw W. C., Senécal J. L., Bordwell B., Johnson P., Rothfield N. F. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. Arthritis Rheum. 1988 Mar;31(3):378–385. doi: 10.1002/art.1780310309. [DOI] [PubMed] [Google Scholar]
  69. Weiner E. S., Hildebrandt S., Senécal J. L., Daniels L., Noell S., Joyal F., Roussin A., Earnshaw W., Rothfield N. F. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. Arthritis Rheum. 1991 Jan;34(1):68–77. doi: 10.1002/art.1780340111. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES